DekaBank Deutsche Girozentrale - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2021$124,000
-22.5%
28,0000.0%0.00%
Q2 2021$160,000
-14.4%
28,0000.0%0.00%
-100.0%
Q1 2021$187,000
+52.0%
28,0000.0%0.00%
Q4 2020$123,000
+29.5%
28,000
+233.8%
0.00%
-100.0%
Q4 2019$95,000
-12.0%
8,389
-68.9%
0.00%0.0%
Q3 2019$108,000
-82.5%
26,989
-40.8%
0.00%
-66.7%
Q2 2019$616,000
-29.3%
45,589
+87.4%
0.00%
-40.0%
Q1 2019$871,000
+134.8%
24,333
+17.9%
0.01%
+150.0%
Q4 2018$371,000
-57.4%
20,633
-15.2%
0.00%
-60.0%
Q3 2018$871,000
-18.5%
24,333
+2.5%
0.01%
-28.6%
Q2 2018$1,069,000
-14.9%
23,7500.0%0.01%
-22.2%
Q1 2018$1,256,000
-63.4%
23,750
-50.3%
0.01%
-66.7%
Q4 2017$3,431,0000.0%47,8000.0%0.03%0.0%
Q3 2017$3,431,000
+13.7%
47,800
+45.7%
0.03%
+12.5%
Q2 2017$3,018,000
+46.5%
32,8000.0%0.02%
+26.3%
Q1 2017$2,060,000
+88.0%
32,800
+32.8%
0.02%
+58.3%
Q4 2016$1,096,000
+38.7%
24,700
+8.3%
0.01%
+33.3%
Q3 2016$790,000
+130.3%
22,8000.0%0.01%
+125.0%
Q2 2016$343,000
+8.2%
22,800
+38.2%
0.00%0.0%
Q1 2016$317,000
-52.5%
16,500
-14.9%
0.00%
-50.0%
Q4 2015$667,000
-62.2%
19,400
+1.0%
0.01%
-63.6%
Q3 2015$1,766,000
+21.5%
19,200
+16.0%
0.02%
+29.4%
Q2 2015$1,454,000
+22.8%
16,550
+3.8%
0.02%
+13.3%
Q1 2015$1,184,000
+17.9%
15,950
-12.4%
0.02%
+15.4%
Q4 2014$1,004,000
+11.2%
18,200
-8.5%
0.01%
+8.3%
Q3 2014$903,000
+11.9%
19,900
+2.1%
0.01%0.0%
Q2 2014$807,000
-44.0%
19,500
-6.2%
0.01%
-47.8%
Q1 2014$1,441,000
+26.8%
20,800
+7.5%
0.02%
+21.1%
Q4 2013$1,136,000
+10.9%
19,350
+14.8%
0.02%
+5.6%
Q3 2013$1,024,000
+13.1%
16,850
+26.7%
0.02%0.0%
Q2 2013$905,00013,3000.02%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders